Does guideline adherence from the first attack improve disease duration and outcomes in patients with difficult-to-treat recurrent pericarditis?
Adherence to guidelines from the first attack of recurrent pericarditis is associated with a shorter disease course, highlighting the importance of early guideline-directed therapy.
This study reports the largest and longest follow-up in patients with recurrent pericarditis. Guideline adherence from the first attack is associated with a shorter course. The disease was long and impacting in terms of recurrences and hospitalizations, often requiring a long-term treatment, in particular with anti-IL-1 agents.
Ceriani et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: